Suchergebnisse - "Ziepert, Marita"

PubPharm (9)

1

The "Burkitt-like" immunophenotype and genotype is rarely encountered in diffuse large B cell lymphoma and high-grade B cell lymphoma, NOS

enthalten in: Virchows Archiv : an international journal of pathology | 2021

von Hüttl, K. | Staiger, A. | Richter, J. | +9

2

Identification of a miRNA based model to detect prognostic subgroups in patients with aggressive B-cell lymphoma

enthalten in: Leukemia & lymphoma | 2021

von Nordmo, C. | Glehr, G. | Altenbuchinger, M. | +11

3

The impact of SOCS1 mutations in diffuse large B-cell lymphoma

enthalten in: British journal of haematology | 2019

von Mellert, K. | Martin, M. | Lennerz, J. | +15

4

Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma : A Study by the Lunenburg Lymphoma Biomarker Consortium

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2019

von Rosenwald, A. | Bens, S. | Advani, R. | +33

5

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma

enthalten in: Blood | 2016

von Mansouri, L. | Noerenberg, D. | Young, E. | +52

CommentIn: Blood. 2016 Dec 8;128(23 ):2591-2592. - PMID 27932324

6

MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma

enthalten in: Blood | 2013

von Horn, H. | Ziepert, M. | Becher, C. | +18

CommentIn: Blood. 2013 Mar 21;121(12):2165-6. - PMID 23520325

7

Circulating levels of TNF receptor II are prognostic for patients with peripheral T-cell non-Hodgkin lymphoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2012

von Heemann, C. | Kreuz, M. | Stoller, I. | +8

8

Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL

enthalten in: Blood | 2010

von Ott, G. | Ziepert, M. | Klapper, W. | +19

9

Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials

enthalten in: Haematologica | 2009

von Bernd, H. | Ziepert, M. | Thorns, C. | +18

1
[1]